MB
TWST icon

MPM BioImpact’s Twist Bioscience TWST Stock Holding History

MPM BioImpact’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-261,215
Closed -$10.3M – 50
2025
Q1 		$10.3M Sell
261,215
-6,282
-2% -$283K 1.76% 25
2024
Q4 		$12.4M Sell
267,497
-27,433
-9% -$1.24M 1.76% 26
2024
Q3 		$13.3M Buy
+294,930
New +$14M 2% 18

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

MPM BioImpact's TWST Position: Q2 2025 in Review

MPM BioImpact sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 261,215 shares — an estimated $10.3M sold.

MPM BioImpact first reported a position in TWST in Q3 2024 and held it in 3 quarters. The position peaked at $13.3M in Q3 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • MPM BioImpact reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • MPM BioImpact sold 261,215 Twist Bioscience shares in Q2 2025, an estimated $10.3M.
  • MPM BioImpact first reported a position in Twist Bioscience in Q3 2024 and held it in 3 quarters.
  • MPM BioImpact's Twist Bioscience position peaked at $13.3M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on MPM BioImpact's 13F filing for Q2 2025, filed 14 Aug 2025.